Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 85509-1035

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 85509-1035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Phoenix Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (1035 3)

Label (1035 3)
This is a description of an extended-release capsule containing Cyclobenzaprine hydrochloride USP, 15 mg. The usual dosage is one or two capsules daily at the same time each day. It should be stored at 20° to 25°C. The medication comes in a container dispensed by a pharmaceutical company and should be kept out of the reach of children.*
FDA Label Image

Structural Formula (Image 1)

Structural Formula (Image 1)
FDA Label Image

Image (Image 2)

Image (Image 2)
FDA Label Image

Image (Image 3)

Image (Image 3)
FDA Label Image

Image (Image 4)

Image (Image 4)
FDA Label Image

Image (Image 5)

Image (Image 5)
FDA Label Image

Image (Image 6)

Image (Image 6)
FDA Label Image

Image (Image 7)

Image (Image 7)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.